-
EDITORIAL
30 Years of Transforming the CDMO Industry – A Chemist’s Perspective
M. Nonnenmacher
-
ADVERTORIAL
Wuxi Tides – Accelerating Complex Oligonucleotide Therapies
-
PHARMA SUPPLY CHAIN
Securing supply chain certainty: strategies for resilience and risk management
J. Donovan
-
OLIGONUCLEOTIDES AND PEPTIDES
Investigating the synthesis of dodeca oligomers of Sarcosine using Fmoc-Sar-OH, Fmoc-(Sar)2-OH and Fmoc-(Sar)4-OH
H. Nzama, K.P Nandhini, K. Rustler, R. Maier, T. Bruckdorfer, B. G. de la Torre, F. Albericio
-
ADVERTORIAL
YMC – The Future of Gene Therapy Manufacturing: Focus on Innovative Purification Solutions
-
ARTIFICIAL INTELLIGENCE
Artificial Intelligence for Life Science and Materials Science Innovations
O. May
-
ARTIFICIAL INTELLIGENCE
Preparing for an AI future that’s already here
J. Bryant
-
DRUG FORMULATION DEVELOPMENT
Concentration and complexity: how formulation is the lynchpin for biologic development
W. McDowell
-
COLUMN: M&A CATALYST
Distress to Recovery: Solutions for EU Chemical SMEs Overcoming Energy Costs, Inflation and Debt in Challenging Times
A. Comanita, J. Meissonnier
-
REPORT
REPORT – 15th CFRT for Industrial Applications Symposium
-
Panel Discussion on… PROTACs
-
IOPC 2025 – Conference abstracts
